JNJ

Johnson & Johnson

$277.60

3.18 (1.13%) Today

— up— down

Compare JNJ

Market Cap

$675.92B+43.2%

Revenue (TTM)

$97.66B+7.8%

Net Income (TTM)

$15.86B-36.4%

EPS (TTM)

6.59-36.4%

Shares Out

2.41B

P/E Ratio

41.96

Forward P/E

23.73

Dividend

$5.14 (3.12%)

Ex-Dividend Date

Aug 25, 2026

Open

$277.96

Previous Close

$280.78

Day Range

$276.61 – $278.66

52-Week Range

$193.07 – $283.25

Beta

0.17

Earnings Date

Jan 26, 2027

Volume

1.39M

Avg Volume

7.26M

Analyst Rating

Buy

Exchange

NEW YORK STOCK EXCHANGE, INC.

About JNJ

Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 42 on the 2026 Fortune 500 list of the largest United States corporations. In 2026, the company was ranked 43rd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.